Loading…

Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory

Background: Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychede...

Full description

Saved in:
Bibliographic Details
Published in:Journal of psychopharmacology (Oxford) 2019-09, Vol.33 (9), p.1076-1087
Main Authors: Roseman, Leor, Haijen, Eline, Idialu-Ikato, Kelvin, Kaelen, Mendel, Watts, Rosalind, Carhart-Harris, Robin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c365t-fe72e821de1c12fbfbf4a44ab39258c99d5364ef241b54710ec0198e092b91003
cites cdi_FETCH-LOGICAL-c365t-fe72e821de1c12fbfbf4a44ab39258c99d5364ef241b54710ec0198e092b91003
container_end_page 1087
container_issue 9
container_start_page 1076
container_title Journal of psychopharmacology (Oxford)
container_volume 33
creator Roseman, Leor
Haijen, Eline
Idialu-Ikato, Kelvin
Kaelen, Mendel
Watts, Rosalind
Carhart-Harris, Robin
description Background: Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychedelics yet here we demonstrate the importance of another component, namely: emotional breakthrough. Methods: Three hundred and seventy-nine participants completed online surveys before and after a planned psychedelic experience. Items pertaining to emotional breakthrough were completed one day after the psychedelic experience, as were items comprising the already validated Mystical Experience Questionnaire and the Challenging Experience Questionnaire. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores were used to predict changes in well-being (Warwick-Edinburgh Mental Wellbeing Scale) in a subsample of 75 participants with low well-being baseline scores (⩽45). Results: Factor analyses revealed six emotional breakthrough items with high internal consistency (Cronbach’s alpha=0.932) and supported our prior hypothesis that emotional breakthrough is a distinct component of the psychedelic experience. Emotional breakthrough scores behaved dose-dependently, and were higher if the psychedelic was taken with therapeutic planning and intent. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores combined, significantly predicted subsequent changes in well-being (r=0.45, p=0.0005, n=75), with each scale contributing significant predictive value. Emotional breakthrough and Mystical Experience Questionnaire scores predicted increases in well-being and Challenging Experience Questionnaire scores predicted less increases. Conclusions: Here we validate a six-item ‘Emotional Breakthrough Inventory’. Emotional breakthrough is an important and distinct component of the acute psychedelic experience that appears to be a key mediator of subsequent longer-term psychological changes. Implications for psychedelic therapy are discussed.
doi_str_mv 10.1177/0269881119855974
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2256098501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_0269881119855974</sage_id><sourcerecordid>2256098501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-fe72e821de1c12fbfbf4a44ab39258c99d5364ef241b54710ec0198e092b91003</originalsourceid><addsrcrecordid>eNp1kL1PwzAQxS0EglLYmVAkFpaAz7GdmA2qApWQWICFIXKcCw2kcbETpP73OGr5EBK64Yb7vXd6j5AjoGcAaXpOmVRZBgAqE0KlfIuMgEuIU5aJbTIazvFw3yP73r9SCpJLsUv2EmCKyzQZkefpwna1bXUTFQ71Wzd3tn-ZR7oto6VfmTmW2NTGX0RPuqlLPbCRraJujtGP9Oq3dNZ-YNtZtzogO5VuPB5u9pg8Xk8fJrfx3f3NbHJ5F5tEii6uMGWYMSgRDLCqCMM157pIFBOZUaoUieRYMQ6F4ClQNDQERqpYoYDSZExO175LZ9979F2-qL3BptEt2t7njAlJQ0MUAnryB321vQsRBioQXDLGA0XXlHHWe4dVvnT1QrtVDjQfis__Fh8kxxvjvlhg-S34ajoA8Rrw-gV_vv5r-AmWPIp2</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2285046224</pqid></control><display><type>article</type><title>Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory</title><source>Sage Journals Online</source><creator>Roseman, Leor ; Haijen, Eline ; Idialu-Ikato, Kelvin ; Kaelen, Mendel ; Watts, Rosalind ; Carhart-Harris, Robin</creator><creatorcontrib>Roseman, Leor ; Haijen, Eline ; Idialu-Ikato, Kelvin ; Kaelen, Mendel ; Watts, Rosalind ; Carhart-Harris, Robin</creatorcontrib><description>Background: Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychedelics yet here we demonstrate the importance of another component, namely: emotional breakthrough. Methods: Three hundred and seventy-nine participants completed online surveys before and after a planned psychedelic experience. Items pertaining to emotional breakthrough were completed one day after the psychedelic experience, as were items comprising the already validated Mystical Experience Questionnaire and the Challenging Experience Questionnaire. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores were used to predict changes in well-being (Warwick-Edinburgh Mental Wellbeing Scale) in a subsample of 75 participants with low well-being baseline scores (⩽45). Results: Factor analyses revealed six emotional breakthrough items with high internal consistency (Cronbach’s alpha=0.932) and supported our prior hypothesis that emotional breakthrough is a distinct component of the psychedelic experience. Emotional breakthrough scores behaved dose-dependently, and were higher if the psychedelic was taken with therapeutic planning and intent. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores combined, significantly predicted subsequent changes in well-being (r=0.45, p=0.0005, n=75), with each scale contributing significant predictive value. Emotional breakthrough and Mystical Experience Questionnaire scores predicted increases in well-being and Challenging Experience Questionnaire scores predicted less increases. Conclusions: Here we validate a six-item ‘Emotional Breakthrough Inventory’. Emotional breakthrough is an important and distinct component of the acute psychedelic experience that appears to be a key mediator of subsequent longer-term psychological changes. Implications for psychedelic therapy are discussed.</description><identifier>ISSN: 0269-8811</identifier><identifier>EISSN: 1461-7285</identifier><identifier>DOI: 10.1177/0269881119855974</identifier><identifier>PMID: 31294673</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Emotions ; Psychedelic drugs ; Questionnaires</subject><ispartof>Journal of psychopharmacology (Oxford), 2019-09, Vol.33 (9), p.1076-1087</ispartof><rights>The Author(s) 2019</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-fe72e821de1c12fbfbf4a44ab39258c99d5364ef241b54710ec0198e092b91003</citedby><cites>FETCH-LOGICAL-c365t-fe72e821de1c12fbfbf4a44ab39258c99d5364ef241b54710ec0198e092b91003</cites><orcidid>0000-0002-6062-7150 ; 0000-0001-9990-6029</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,79364</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31294673$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Roseman, Leor</creatorcontrib><creatorcontrib>Haijen, Eline</creatorcontrib><creatorcontrib>Idialu-Ikato, Kelvin</creatorcontrib><creatorcontrib>Kaelen, Mendel</creatorcontrib><creatorcontrib>Watts, Rosalind</creatorcontrib><creatorcontrib>Carhart-Harris, Robin</creatorcontrib><title>Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory</title><title>Journal of psychopharmacology (Oxford)</title><addtitle>J Psychopharmacol</addtitle><description>Background: Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychedelics yet here we demonstrate the importance of another component, namely: emotional breakthrough. Methods: Three hundred and seventy-nine participants completed online surveys before and after a planned psychedelic experience. Items pertaining to emotional breakthrough were completed one day after the psychedelic experience, as were items comprising the already validated Mystical Experience Questionnaire and the Challenging Experience Questionnaire. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores were used to predict changes in well-being (Warwick-Edinburgh Mental Wellbeing Scale) in a subsample of 75 participants with low well-being baseline scores (⩽45). Results: Factor analyses revealed six emotional breakthrough items with high internal consistency (Cronbach’s alpha=0.932) and supported our prior hypothesis that emotional breakthrough is a distinct component of the psychedelic experience. Emotional breakthrough scores behaved dose-dependently, and were higher if the psychedelic was taken with therapeutic planning and intent. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores combined, significantly predicted subsequent changes in well-being (r=0.45, p=0.0005, n=75), with each scale contributing significant predictive value. Emotional breakthrough and Mystical Experience Questionnaire scores predicted increases in well-being and Challenging Experience Questionnaire scores predicted less increases. Conclusions: Here we validate a six-item ‘Emotional Breakthrough Inventory’. Emotional breakthrough is an important and distinct component of the acute psychedelic experience that appears to be a key mediator of subsequent longer-term psychological changes. Implications for psychedelic therapy are discussed.</description><subject>Emotions</subject><subject>Psychedelic drugs</subject><subject>Questionnaires</subject><issn>0269-8811</issn><issn>1461-7285</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kL1PwzAQxS0EglLYmVAkFpaAz7GdmA2qApWQWICFIXKcCw2kcbETpP73OGr5EBK64Yb7vXd6j5AjoGcAaXpOmVRZBgAqE0KlfIuMgEuIU5aJbTIazvFw3yP73r9SCpJLsUv2EmCKyzQZkefpwna1bXUTFQ71Wzd3tn-ZR7oto6VfmTmW2NTGX0RPuqlLPbCRraJujtGP9Oq3dNZ-YNtZtzogO5VuPB5u9pg8Xk8fJrfx3f3NbHJ5F5tEii6uMGWYMSgRDLCqCMM157pIFBOZUaoUieRYMQ6F4ClQNDQERqpYoYDSZExO175LZ9979F2-qL3BptEt2t7njAlJQ0MUAnryB321vQsRBioQXDLGA0XXlHHWe4dVvnT1QrtVDjQfis__Fh8kxxvjvlhg-S34ajoA8Rrw-gV_vv5r-AmWPIp2</recordid><startdate>201909</startdate><enddate>201909</enddate><creator>Roseman, Leor</creator><creator>Haijen, Eline</creator><creator>Idialu-Ikato, Kelvin</creator><creator>Kaelen, Mendel</creator><creator>Watts, Rosalind</creator><creator>Carhart-Harris, Robin</creator><general>SAGE Publications</general><general>Sage Publications Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-6062-7150</orcidid><orcidid>https://orcid.org/0000-0001-9990-6029</orcidid></search><sort><creationdate>201909</creationdate><title>Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory</title><author>Roseman, Leor ; Haijen, Eline ; Idialu-Ikato, Kelvin ; Kaelen, Mendel ; Watts, Rosalind ; Carhart-Harris, Robin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-fe72e821de1c12fbfbf4a44ab39258c99d5364ef241b54710ec0198e092b91003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Emotions</topic><topic>Psychedelic drugs</topic><topic>Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Roseman, Leor</creatorcontrib><creatorcontrib>Haijen, Eline</creatorcontrib><creatorcontrib>Idialu-Ikato, Kelvin</creatorcontrib><creatorcontrib>Kaelen, Mendel</creatorcontrib><creatorcontrib>Watts, Rosalind</creatorcontrib><creatorcontrib>Carhart-Harris, Robin</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of psychopharmacology (Oxford)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Roseman, Leor</au><au>Haijen, Eline</au><au>Idialu-Ikato, Kelvin</au><au>Kaelen, Mendel</au><au>Watts, Rosalind</au><au>Carhart-Harris, Robin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory</atitle><jtitle>Journal of psychopharmacology (Oxford)</jtitle><addtitle>J Psychopharmacol</addtitle><date>2019-09</date><risdate>2019</risdate><volume>33</volume><issue>9</issue><spage>1076</spage><epage>1087</epage><pages>1076-1087</pages><issn>0269-8811</issn><eissn>1461-7285</eissn><abstract>Background: Psychedelic therapy is gaining recognition and the nature of the psychedelic experience itself has been found to mediate subsequent long-term psychological changes. Much emphasis has been placed on the occurrence of mystical-type experiences in determining long-term responses to psychedelics yet here we demonstrate the importance of another component, namely: emotional breakthrough. Methods: Three hundred and seventy-nine participants completed online surveys before and after a planned psychedelic experience. Items pertaining to emotional breakthrough were completed one day after the psychedelic experience, as were items comprising the already validated Mystical Experience Questionnaire and the Challenging Experience Questionnaire. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores were used to predict changes in well-being (Warwick-Edinburgh Mental Wellbeing Scale) in a subsample of 75 participants with low well-being baseline scores (⩽45). Results: Factor analyses revealed six emotional breakthrough items with high internal consistency (Cronbach’s alpha=0.932) and supported our prior hypothesis that emotional breakthrough is a distinct component of the psychedelic experience. Emotional breakthrough scores behaved dose-dependently, and were higher if the psychedelic was taken with therapeutic planning and intent. Emotional breakthrough, Mystical Experience Questionnaire and Challenging Experience Questionnaire scores combined, significantly predicted subsequent changes in well-being (r=0.45, p=0.0005, n=75), with each scale contributing significant predictive value. Emotional breakthrough and Mystical Experience Questionnaire scores predicted increases in well-being and Challenging Experience Questionnaire scores predicted less increases. Conclusions: Here we validate a six-item ‘Emotional Breakthrough Inventory’. Emotional breakthrough is an important and distinct component of the acute psychedelic experience that appears to be a key mediator of subsequent longer-term psychological changes. Implications for psychedelic therapy are discussed.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>31294673</pmid><doi>10.1177/0269881119855974</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-6062-7150</orcidid><orcidid>https://orcid.org/0000-0001-9990-6029</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0269-8811
ispartof Journal of psychopharmacology (Oxford), 2019-09, Vol.33 (9), p.1076-1087
issn 0269-8811
1461-7285
language eng
recordid cdi_proquest_miscellaneous_2256098501
source Sage Journals Online
subjects Emotions
Psychedelic drugs
Questionnaires
title Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T16%3A25%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Emotional%20breakthrough%20and%20psychedelics:%20Validation%20of%20the%20Emotional%20Breakthrough%20Inventory&rft.jtitle=Journal%20of%20psychopharmacology%20(Oxford)&rft.au=Roseman,%20Leor&rft.date=2019-09&rft.volume=33&rft.issue=9&rft.spage=1076&rft.epage=1087&rft.pages=1076-1087&rft.issn=0269-8811&rft.eissn=1461-7285&rft_id=info:doi/10.1177/0269881119855974&rft_dat=%3Cproquest_cross%3E2256098501%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c365t-fe72e821de1c12fbfbf4a44ab39258c99d5364ef241b54710ec0198e092b91003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2285046224&rft_id=info:pmid/31294673&rft_sage_id=10.1177_0269881119855974&rfr_iscdi=true